Series A · AI
Mithrl raises $20m Series A for second-generation platform rollout
Its biomedical world model combines scientific literature with partner and proprietary datasets.
The capital will support rollout of Mithrl-1, the company’s second-generation platform for pharmaceutical companies, clinical-stage biotechs and genomics partners.
Mithrl-1 adds orchestration for model routing, token efficiency and context management. The planned release extends the company’s biomedical world-model approach into agent workflows that connect generated insights to underlying research evidence.
Use of funds
Roll out the second-generation Mithrl-1 platform
Funding history
Series A · This round$20M